121 results on '"Borgia S"'
Search Results
2. Global real-world evidence of sofosbuvir/velpatasvir (SOF/VEL) as a highly effective treatment in underserved patient populations because of mental health disorders, incarceration or homelessness
3. Changing HCV patient profiles: insights from a large multinational real-world sofosbuvir/velpatasvir (SOF/VEL) dataset
4. Global real-world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts
5. Global real-world evidence of sofosbuvir/velpatasvir (SOF/VEL) as a highly effective treatment in underserved patient populations because of mental health disorders, incarceration or homelessness
6. Cloning of a Chromosomal Region Responsible for Streptolysin S Production in Streptococcus pyogenes
7. In vitro skin absorption and drug release – A comparison of six commercial prednicarbate preparations for topical use
8. Carbapenemase-producing Enterobacterales in hospital drains in Southern Ontario, Canada
9. Lipid nanoparticles for skin penetration enhancement—correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy
10. Sofosbuvir-velpatasvir for 12 weeks is safe and effective in patients undergoing dialysis.
11. Group A Streptococcal Sepsis Secondary to Peritonitis and Acute Pelvic Inflammatory Disease
12. Cloning of a Chromosomal Region Responsible for Streptolysin S Production in Streptococcus pyogenes
13. A191 HCV SCREENING VIA RAPID POINT OF CARE TESTING IN PATIENTS ON OPIATE SUBSTITUTION THERAPY IN PEEL REGION, CANADA
14. Z-PROFILE: Real-world utilization and effectiveness of elbasvir/ grazoprevir in adult patients with chronic hepatitis C in Canada
15. A188 REAL-LIFE MANAGEMENT OF CHRONIC HEPATITIS C VIRUS INFECTION IN CANADA: DESCRIPTION OF PATIENT PROFILE, PROGNOSTIC FACTORS AND TREATMENT STRATEGIES
16. Real-world utilization of the new fixed-dose combination elbasvir/grazoprevir in adult patients with chronic hepatitis C in Canada: Z-PROFILE study
17. Machine Tool Energetic Simulation during General Milling Operations
18. EMC2-Factory Project - D8.2 - EMC2-Factory pilot demonstrators for the Automotive industry
19. Ledipasvir/Sofosbuvir with Ribavirin for 12 Weeks is Effective and Safe in Treatment-Naïve Genotype-3 Hepatitis C-Infected Patients in Canada
20. THU-369 - Z-PROFILE: Real-world utilization and effectiveness of elbasvir/ grazoprevir in adult patients with chronic hepatitis C in Canada
21. ENEPLAN Project - D3.2 - Models for the integrated process and production planning (v. 2)
22. EMC2 Factory Project - D4.2 - Intelligent systems components with enhanced control strategies
23. MACHINE TOOL ENERGY ANALYSIS IN GENERAL MILLING OPERATIONS
24. ENEPLAN Project - D2.2 - Process simulation models
25. ENEPLAN Project - D1.1 - Energy and eco-efficiency of machine tools, processes and handling equipment
26. ESTOMAD Project - D5.5 - Verification on industrial use cases
27. ESTOMAD Project - D3.3 - 'Design for energy efficiency' approach
28. ESTOMAD Project - D5.3 - Machine Tool Application
29. ESTOMAD Project - D3.2 - Verification on system benchmarks
30. ESTOMAD Project - D3.1 - Scenario and framework development
31. ESTOMAD Project - D2.3 - Verification on component/subsystem benchmarks
32. Quote Generation for Special Tools: an Ontology-based Method
33. Design of flexible transfer lines in dynamic market environments: a configuration approach
34. Distributed Tracking, Storage, and Re-use of Job State Information on the Grid
35. Pratical approaches to Grid workload and resource management in the EGEE project
36. Pratical Approaches to Grid Workload and Resource Management in the EGEE Project
37. Distributed Tracking, Storage, and Re-use of Job State Information on the Grid
38. SAT-183 - Ledipasvir/Sofosbuvir with Ribavirin for 12 Weeks is Effective and Safe in Treatment-Naïve Genotype-3 Hepatitis C-Infected Patients in Canada
39. Network part program approach based on the STEP-NC data structure for the machining of multiple fixture pallets
40. Outbreak of Carbapenem-Resistant Enterobacteriaceae Containing blaNDM-1, Ontario, Canada
41. Brucellosis in a returned traveller
42. The Phenion® Full-Thickness Skin Model for Percutaneous Absorption Testing
43. Lipid nanoparticles for skin penetration enhancement—correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy
44. Design and in vitro-in vivo evaluation of a bi-layered tablet containing benzocaine for local buccal administration
45. Mucoadhesive Tablets for Buccal Administration Containing Sodium Nimesulide
46. In vitro permeation through porcine buccal mucosa of caffeic acid phenetyl ester (CAPE) from a topical mucoadhesive gel containing propolis
47. Correlation Between the Transdermal Permeation of Ketoprofen and its Solubility in Mixtures of a pH 6.5 Phosphate Buffer and Various Solvents
48. Development of a Mucoadhesive Dosage Form for Vaginal Administration
49. Network part program approach based on the STEP-NC data structure for the machining of multiple fixture pallets.
50. Prevalence and Mechanisms of Macrolide Resistance in Clinical Isolates of Group A Streptococci from Ontario, Canada
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.